3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
44
Lymphoma, Mantle-Cell
30
Lymphoma
28
Lymphoma, Follicular
27
Leukemia, Lymphocytic, Chronic, B-Cell
26
Lymphoma, Non-Hodgkin
25
Lymphoma, B-Cell, Marginal Zone
16
Lymphoma, B-Cell
14
Recurrence
12
Burkitt Lymphoma
12
Waldenstrom Macroglobulinemia
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Hodgkin Disease
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
trametinib
1
olaparib
1
dabrafenib
1
Vemurafenib
1
Pharmacogenomic Variants
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytosis, Langerhans-Cell
×
Rituximab
×
90 days
×
Clear all
No trials found.